Stephen G. Carter

70 year

Health Technology

Consumer Non-Durables

Profile

Stephen G.
Carter worked as the Director, Chief Scientific Officer & VP at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He also worked as the Chief Scientific Officer at Biochemics, Inc.

Former positions of Stephen G. Carter

Companies	Position	End
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Chief Tech/Sci/R&D Officer	2012-11-05
Biochemics, Inc. Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA.	Chief Tech/Sci/R&D Officer	-

See the detail of Stephen G. Carter's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen G. Carter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Health Technology
Biochemics, Inc. Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA.	Consumer Non-Durables